<DOC>
	<DOCNO>NCT01707901</DOCNO>
	<brief_summary>A random control study investigate effect new drug , ONO-8539 , oesophageal pain hypersensitivity patient gastric reflux disease</brief_summary>
	<brief_title>A Study Effect ONO-8539 Oesophageal Pain Hypersensitivity Patients With Non-erosive Reflux Disease</brief_title>
	<detailed_description>This Randomised , Double-blind , Placebo-controlled , Two-period Crossover Study Investigate Effect ONO-8539 Oesophageal Pain Hypersensitivity Patients With Non-erosive Reflux Disease</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Male female subject age 1870 year inclusive confirm GERD normal oesophageal mucosa enrol study . Subjects demonstrate moderate intensity heartburn stable dose proton pump inhibitor demonstrate oesophageal hypersensitivity follow distal oesophageal acid perfusion . Subjects exclude motility disorder , able tolerate study procedure GI surgery condition would affect study result . Subjects functional heartburn , acute GI symptom , endoscopic manometric abnormality protocolspecified cardiovascular condition enrol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>GERD</keyword>
</DOC>